logo

For the Inventor, By the Inventor

Milan, Italy

Bruno Cavalleri

USPTO Granted Patents = 26

Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 139(Granted Patents)


Location History:

  • Milano, IT (1987)
  • Milan, IT (1976 - 1994)
  • Pierlombardo, IT (1996)

Company Filing History:

goldMedal25 out of 188 
 
Gruppo Lepetit
 patents
silverMedal1 out of 455 
 
Merrell Dow Pharmaceuticals
 patents

Years Active: 1976-1996

Loading Chart...
26 patents (USPTO):Explore Patents
1. 5491128 - Aglycons of A/16686 antibiotics (1996-02-13),
2. 5306715 - Rifapentine hydrohalides (1994-04-26),
3. 5132286 - Composition of antibiotic L 17054 and a method for the treatment of (1992-07-21),
4. 5108988 - Hydrogenated derivatives of antibiotic A/16686 (1992-04-28),
5. 5041534 - Process for preparing antibiotic L 17054 (1991-08-20),
6. 4954483 - Carboxylic acid ester derivatives or deglucoteicoplanin (1990-09-04),
7. 4914187 - Ester derivatives of antibiotic L 17046 (1990-04-03),
8. 4882419 - Process for preparing antibiotic L 17392 (deglucoteicoplanin) (1989-11-21),
9. 4880789 - 2'-Substituted-4-deoxy-thiazolo(5,4-c)-rifamycin SV derivatives (1989-11-14),
10. 4725668 - Process for transforming teicoplanin factor A.sub.2 component 1 into (1988-02-16),
11. 4699977 - Antibiotic L 17046 and process for preparing it (1987-10-13),
12. 4698418 - Process for preparing antibiotic L 17046 (1987-10-06),
13. 4684644 - Basic monocarboxyamide derivatives of actagardine having antibiotic (1987-08-04),
14. 4661470 - Ester derivatives of antibiotic L 17046 (1987-04-28),
15. 4650855 - Glycopeptide antibiotic L 17046 (1987-03-17),

Title: The Innovative Mind of Bruno Cavalleri from Milan

Introduction:

Bruno Cavalleri, a prolific inventor based in Milan, Italy, has left a remarkable mark in the field of antibiotic research with a total of 26 patents under his name. His groundbreaking inventions have revolutionized the treatment of wound infections and acne, showcasing his dedication to advancing medical science.

Latest Patents:

Among his latest patents is the discovery of Aglycons of A/16686 antibiotics. This invention focuses on the aglycons of factors A1, A2, A3, A'1, A'2, A'3 of antibiotic A/16686, demonstrating antibacterial activity against gram-positive bacteria. These compounds have proven to be highly effective in the topical treatment of various infections, highlighting Bruno Cavalleri's commitment to improving healthcare.

Additionally, Bruno Cavalleri has patented Rifapentine hydrohalides, indicating his versatility and expertise in the pharmaceutical industry. These innovations underscore his profound impact on the development of novel therapeutic solutions.

Career Highlights:

Throughout his career, Bruno Cavalleri has made significant contributions to renowned companies such as Gruppo Lepetit S.p.A. and Merrell Dow Pharmaceuticals. His invaluable expertise and innovative spirit have propelled these organizations to new heights in the pharmaceutical sector, earning him a stellar reputation in the industry.

Collaborations:

Bruno Cavalleri has collaborated with esteemed professionals including Adriano Malabarba and Paolo Strazzolini. Together, they have collectively pushed the boundaries of scientific discovery and achieved remarkable milestones in the field of antibiotic research.

Conclusion:

In conclusion, Bruno Cavalleri's remarkable journey as an inventor exemplifies his unwavering dedication to advancing medical science and improving patient care. His pioneering work in antibiotic research continues to inspire future generations of innovators, making him a true visionary in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…